Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.
2016.
Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.
2016.
Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
Kuceyeski A, Navi BB, Kamel H, Raj A, Relkin N, Toglia J, Iadecola C, O'Dell M.
2016.
Structural connectome disruption at baseline predicts 6-months post-stroke outcome.. Hum Brain Mapp. 37(7):2587-601.
Kuceyeski A, Navi BB, Kamel H, Raj A, Relkin N, Toglia J, Iadecola C, O'Dell M.
2016.
Structural connectome disruption at baseline predicts 6-months post-stroke outcome.. Hum Brain Mapp. 37(7):2587-601.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.
2016.
A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS.
2016.
A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.
Liu W, Zhao L, Blackman B, Parmar M, Wong MYing, Woo T, Yu F, Chiuchiolo MJ, Sondhi D, Kaminsky SM et al..
2016.
Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.. J Neurosci. 36(49):12425-12435.